UBS Cuts Price Target on Merck to $120 From $125, Maintains Buy Rating

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.29 USD | +0.34% |
|
-3.60% | -16.27% |
Feb. 18 | Merck Agrees to Halt Gardasil Trial Until September | MT |
Feb. 18 | Merck vaccine case linked to HHS Secretary Kennedy delayed mid-trial | RE |